CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Menu
Begin main content
Home Search
Result Type
Evidence Bundles
Product Line
Body Systems
Disease and Conditions
Target Population
Technologies, Therapies and Systems
Testing and Diagnostics
Publication Date
Clear all filters

Reports

We found 236 result(s)

esketamine hydrochloride (Spravato)

Last Updated: December 18, 2020
Result type: Reports
Product Line: Reimbursement Review
Generic Name: esketamine hydrochloride
Indications: Indicated in combination with a SSRI or SNRI, for the treatment of major depressive disorder in adults who have not responded adequately to at least two separate courses of treatment with different antidepressants, each of adequate dose and duration, in the current moderate to severe depressive episode.

  • Brand Name: Spravato
  • Manufacturer: Janssen Inc.
  • Project Number: SR0621-000
  • Project Status: Active
  • Submission Type: Initial
Details

Care for Acquired Brain Injury and Concurrent Mental Health and Substance Use Issues

Last Updated: November 5, 2020
Result type: Reports
Product Line: Environmental Scans

CADTH is undertaking an Environmental Scan of systems and services that are in place in Canada for caring for individuals affected by acquired brain injury (ABI) and concurrent mental health and/or substance use issues. This project is being conducted to help inform decision-making and support practice change to improve the health and well-being...

  • Project Number: ES0339-000
Details

vortioxetine hydrobromide (Trintellix )

Last Updated: April 8, 2020
Result type: Reports
Product Line: Reimbursement Review
Generic Name: vortioxetine hydrobromide
Indications: Major depressive disorder (MDD), adults.

  • Brand Name: Trintellix
  • Manufacturer: Lundbeck Canada Inc.
  • Project Number: SR0611-000
  • Project Status: Complete
  • Submission Type: Initial
Details

Major Depressive Disorder – Focused Critical Appraisal of a Network Meta-Analysis

Last Updated: February 18, 2020
Result type: Reports
Product Line: Technology Review
Research Type: Drug

Major depressive disorder (MDD) is a common, debilitating, and recurrent mental health disorder. Over the past decades, multiple classes of antidepressant drugs have been developed to treat this condition. The relative effectiveness and safety of antidepressants are uncertain. This project will review a recently published network meta-analysis f...

  • Project Number: HE0022-000
Details